243 related articles for article (PubMed ID: 26458806)
1. Optimized oral cholera vaccine distribution strategies to minimize disease incidence: A mixed integer programming model and analysis of a Bangladesh scenario.
Smalley HK; Keskinocak P; Swann J; Hinman A
Vaccine; 2015 Nov; 33(46):6218-23. PubMed ID: 26458806
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
3. Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh.
Sarker AR; Islam Z; Khan IA; Saha A; Chowdhury F; Khan AI; Cravioto A; Clemens JD; Qadri F; Khan JA
Vaccine; 2015 Sep; 33(38):4916-21. PubMed ID: 26232545
[TBL] [Abstract][Full Text] [Related]
4. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh.
Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F
Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.
Qadri F; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Begum YA; Bhuiyan TR; Chowdhury MI; Uddin MJ; Khan JAM; Chowdhury AI; Rahman A; Siddique SA; Asaduzzaman M; Akter A; Khan A; Ae You Y; Siddik AU; Saha NC; Kabir A; Riaz BK; Biswas SK; Begum F; Unicomb L; Luby SP; Cravioto A; Clemens JD
Lancet; 2015 Oct; 386(10001):1362-1371. PubMed ID: 26164097
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh.
Qadri F; Wierzba TF; Ali M; Chowdhury F; Khan AI; Saha A; Khan IA; Asaduzzaman M; Akter A; Khan A; Begum YA; Bhuiyan TR; Khanam F; Chowdhury MI; Islam T; Chowdhury AI; Rahman A; Siddique SA; You YA; Kim DR; Siddik AU; Saha NC; Kabir A; Cravioto A; Desai SN; Singh AP; Clemens JD
N Engl J Med; 2016 May; 374(18):1723-32. PubMed ID: 27144848
[TBL] [Abstract][Full Text] [Related]
7. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis.
Ali M; Emch M; von Seidlein L; Yunus M; Sack DA; Rao M; Holmgren J; Clemens JD
Lancet; 2005 Jul 2-8; 366(9479):44-9. PubMed ID: 15993232
[TBL] [Abstract][Full Text] [Related]
8. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
[TBL] [Abstract][Full Text] [Related]
9. Considerations around the introduction of a cholera vaccine in Bangladesh.
Nelson CB; Mogasale V; Bari TI; Clemens JD
Vaccine; 2014 Dec; 32(52):7033-6. PubMed ID: 24856784
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D; Lopez AL; Kanungo S; Paisley A; Manna B; Ali M; Niyogi SK; Park JK; Sarkar B; Puri MK; Kim DR; Deen JL; Holmgren J; Carbis R; Rao R; Nguyen TV; Donner A; Ganguly NK; Nair GB; Bhattacharya SK; Clemens JD
Lancet; 2009 Nov; 374(9702):1694-702. PubMed ID: 19819004
[TBL] [Abstract][Full Text] [Related]
11. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh.
Clemens J; Sack D; Rao M; Chakraborty J; Kay B; Ahmed F; Khan MR; van Loon FP; Svennerholm AM; Holmgren J
Int J Epidemiol; 1993 Aug; 22(4):724-30. PubMed ID: 8225749
[TBL] [Abstract][Full Text] [Related]
12. Field trial of oral cholera vaccines in Bangladesh.
Clemens JD; Sack DA; Harris JR; Chakraborty J; Khan MR; Stanton BF; Kay BA; Khan MU; Yunus M; Atkinson W
Lancet; 1986 Jul; 2(8499):124-7. PubMed ID: 2873397
[TBL] [Abstract][Full Text] [Related]
13. Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines.
Durham LK; Longini IM; Halloran ME; Clemens JD; Nizam A; Rao M
Am J Epidemiol; 1998 May; 147(10):948-59. PubMed ID: 9596473
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study.
Dimitrov DT; Troeger C; Halloran ME; Longini IM; Chao DL
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3343. PubMed ID: 25473851
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
[TBL] [Abstract][Full Text] [Related]
16. Cholera cases cluster in time and space in Matlab, Bangladesh: implications for targeted preventive interventions.
Debes AK; Ali M; Azman AS; Yunus M; Sack DA
Int J Epidemiol; 2016 Dec; 45(6):2134-2139. PubMed ID: 27789673
[TBL] [Abstract][Full Text] [Related]
17. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
[TBL] [Abstract][Full Text] [Related]
18. Optimal allocation of the limited oral cholera vaccine supply between endemic and epidemic settings.
Moore SM; Lessler J
J R Soc Interface; 2015 Oct; 12(111):20150703. PubMed ID: 26423441
[TBL] [Abstract][Full Text] [Related]
19. Comparing alternative cholera vaccination strategies in Maela refugee camp: using a transmission model in public health practice.
Havumaki J; Meza R; Phares CR; Date K; Eisenberg MC
BMC Infect Dis; 2019 Dec; 19(1):1075. PubMed ID: 31864298
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
